Skip to main content
. 2014 Jan-Feb;7(1):15–22.

Table 2.

Treatment-related AEs

Adverse event Grade 1 Grade 2 Grade 3 Grade 4 Grade 5 Total affected n (%)
Worst grade per patient: severe events, n

Lymphopenia 2 2 5 2 0 11 (85)

Anemia 2 0 1 0 0 3 (23)

Increased INR 0 1 1 0 0 2 (15)

Acute coronary syndrome 0 0 1 0 0 1 (8)

Gastric hemorrhage 0 0 0 0 1 1 (8)

Gastric ulcer 0 0 1 0 0 1 (8)

Hyponatremia 0 0 1 0 0 1 (8)

Worst grade per patient: mild and moderate events, n

Nausea or vomiting 6 1 0 0 0 7 (54)

Fatigue 4 2 0 0 0 6 (46)

Thrombocytopenia 4 1 0 0 0 5 (38)

Anorexia 2 0 0 0 0 2 (15)

Chills 2 0 0 0 0 2 (15)

Leukopenia 1 1 0 0 0 2 (15)

Oral mucositis 1 1 0 0 0 2 (15)

Diarrhea 0 1 0 0 0 1 (8)

Dry skin 1 0 0 0 0 1 (8)

Hand-foot syndrome 0 1 0 0 0 1 (8)

Hypoalbuminemia 1 0 0 0 0 1 (8)

Hypocalcemia 1 0 0 0 0 1 (8)

Hypomagnesemia 1 0 0 0 0 1 (8)

Skin ulceration 1 0 0 0 0 1 (8)

Transaminase elevation 1 0 0 0 0 1 (8)

All events considered to be at least possibly related to treatment are shown.